Bacteriophage PRD1 is an icosahedral dsDNA virus with a diameter of 740 Å and an outer protein shell composed of 720 copies of major coat protein P3. Spike complexes at the vertices are composed of a pentameric base (protein P31) and a spike structure (proteins P5 and P2) where the N-terminal region of the trimeric P5 is associated with the base and the C-terminal region of P5 is associated with receptor-binding protein P2. The functionality of proteins P3 and P5 was investigated using insertions and deletions. It was observed that P3 did not tolerate changes whereas P5 tolerated changes much more freely. These properties support the hypothesis that viruses have core structures and functions, which remain stable over time, as well as other elements, responsible for host interactions, which are evolutionally more fluid. The insertional probe used was the apex of exposed loop 4 of group B meningococcal outer membrane protein PorA, a medically important subunit vaccine candidate. It was demonstrated that the epitope could be displayed on the virus surface as part of spike protein P5.
Introduction
Recent advances in probing the structure of PRD1, a dsDNA bacterial virus with an internal membrane, have revealed intriguing similarities to human adenovirus and have led to proposals of common ancestry (Belnap and Steven, 2000; Benson et al., 1999 Benson et al., , 2002 Hendrix, 1999) as well as made PRD1 amenable to trials for use as an epitope display system. The icosahedral virion, with a diameter of 740 Å from vertex to vertex, has an external protein layer composed of 240 copies of P3 coat protein trimers arranged on a pseudo T ϭ 25 lattice (Butcher et al., 1995) . The icosahedral vertices have a pentameric protein P31 that forms a base for the extending spike structure built of trimeric spike protein P5 and receptor-binding protein P2 Caldentey et al., 2000; Grahn et al., 1999; Rydman et al., 1999) . The high-resolution structure of P3 reveals a monomer with two connected ␤-barrels, V1 and V2, similar to adenovirus hexon (Benson et al., 1999 (Benson et al., , 2002 . V1 displays a tower region extending from the virus surface, which is also seen as a protrusion in cryo-electron microscopy reconstructions (Fig. 1) . Beneath the protein coat resides the viral membrane, which closely follows the icosahedral shape of the capsid (Butcher et al., 1995) . The 15-kbp-long genome is located within the membrane vesicle, a device used by the virus to deliver its DNA to gram-negative host cells Grahn et al., 2002; Lundström et al., 1979; Rydman and Bamford, 2000) .
The cryo-electron microscopy density map of the virion combined with the high-resolution structure of the major coat protein yielded a quasi-atomic model for the capsid (depicted in Fig. 1b ). This model gave information on in-teractions between the coat and the membrane as well as on vertex structure (San Martín et al., 2001 . Recent crystallization of the entire 66-MDa virion and current efforts to resolve its high-resolution structure provide a solid basis for probing the virion through genetic approaches and allow modeling of insertions. The vertex spike has resisted structural analysis because of symmetry mismatch (trimeric P5 associates with pentameric P31) and flexibility. Icosahedral averaging applied in both electron microscopy-based image reconstructions as well as in X-ray analyses abolishes the spike signal. Purified receptor-binding protein P2 has been crystallized (Xu et al., 2000 (Xu et al., , 2003 but no crystals of P5 have been obtained, except for the distal C-terminal domain. The structure of the flexible P5 trimer, however, has been examined with solution scattering techniques (Sokolova et al., 2001) . In this study, the Benson et al., 2002) fitted to the 25-Å reconstruction of PRD1 virion (San Martín et al., 2001) . Density corresponding to P3 is shown in transparent gray and vertices are in red. (b) A close-up of an icosahedral facet. The position of one P3 trimer is depicted. V1 and V2 correspond to the ␤-barrels of one monomer. (c) Secondary structure elements in the P3 monomer. The P3 fold is shown from the side. The upper part of the molecule points outward and the lower part toward the viral membrane. Positions of epitope insertions are denoted. Amino acids replaced by meningococcal epitope structure (pdb:1MPA; van den Elsen et al., 1997) are shown in blue (inset). structure of the spike protein was probed by making insertions and deletions at several positions.
Several epitope display systems have been developed in the past 15 years using infective viruses (De Berardinis et al., 2000; de la Cruz et al., 1988; Maruyama et al., 1994; Porta et al., 1994; Rose et al., 1994; Smith et al., 1994; Sternberg and Hoess, 1995; Jiang et al., 1997) and virus-like particles (Belyaev and Roy, 1992; Gedvilaite et al., 2000; Gilbert et al., 1997; Kratz et al., 1999; Mastico et al., 1993; Pumpens and Grens, 1999; Rueda et al., 1999) . Detailed understanding of the PRD1 system makes it a promising candidate for displaying epitopes on virion surfaces or purified structural proteins. PRD1 has several advantages as an epitope carrier: (1) the high copy number of the epitope is thought to be important in eliciting strong immunological responses; (2) 720 copies of the major coat protein and about 40 copies of the spike protein are exposed on the PRD1 surface; (3) knowledge of the coat protein atomic structure supports rational design; and (4) PRD1 membrane components have adjuvant properties. The epitope probe selected for this study is one of two major immunological determinants of the PorA protein (P1.16 subtype) of group B Neisseria meningitidis, the bacteria that cause severe meningitis in humans. Several previous attempts to use PorA for vaccine development have not been successful.
Results

Modeling of the meningococcal peptide to the surface loops of the coat protein P3
The epitope used in this study was the PorA protein from P1.16 subtype N. meningitidis. PorA forms an amphipathic ␤-barrel embedded in the outer membrane with surfaceexposed antigenic loops. TKDTNNNL peptide in loop 4 defines the P1.16 antigenic specificity. The structure of a fluorescein-conjugated form TKDTNNNLC has been solved by X-ray crystallography (van den Elsen et al., 1997) and it forms a ␤-hairpin in complex with the antigenbinding fragment of monoclonal antibody (Mab) MN12H2. Four loops in the tower region of the large ␤-barrel V1 of PRD1 major coat protein P3 were considered for insertion of this peptide ( Fig. 1c) : BC1 (48 -53), DE1 (79 -95), . Loops DE1 and FG1 are on top of the tower region and thus clearly on the most external part of the protein. Loop BC1 is to the side of V1 and loop HI1 is intertwined on the surface of the protein and contains a short ␣-helix (HI1-␣). The known natural variants of this part of the protein, T77K and E224K, fall near these loop regions (Benson et al., 2002) . The C ␣ -C ␣ distance between the terminal residues of the epitope is 5.5 Å in the crystal structure, and similar C ␣ -C ␣ pairs were searched in selected surface loops of P3. Distances in the five selected pairs ranged from 5.3 to 6.2 Å. Insertions were modeled to these five sites (Fig. 1c) , models were energy-minimized and evaluated for steric hindrance. Since no clashes were observed, all five sites were chosen for epitope insertions. In contrast to P3, in which all loops are between the ␤-strands belonging to two different ␤-sheets, the native loop structure in PorA is formed between neighboring strands in one sheet. Assuming that epitope structure is largely independent of its environment, the epitope could obtain the structure recognized by the antibody when inserted into P3 surface loops.
Epitope insertion interferes with the biological activity of coat protein P3
The biological activity of the recombinant coat proteins was assessed by complementation analysis, in which the increase in titer is due to complementation and recombination. The titer of sus14 mutant virus (P3 Ϫ ) was determined on a bacterial strain carrying a plasmid with the recombinant hybrid coat protein gene. Complementation titers are presented in Table 1 . Introduction of a new restriction enzyme site in the genomic region corresponding to the sur- face loop in the insertion vectors altered the amino acid sequence in three loops: BC1, DE1, and HI1. In BC1 and DE1, an alanine was changed into a glycine. This change did not affect the complementation ability of P3 whereas the change from alanine to proline in loop HI1 had a severe effect. The titer dropped by two orders of magnitude compared to wild-type (wt) P3 (Table 1) . Table 1 shows that insertion of the meningococcal peptide into surface loops strongly interfered with P3 complementation ability. The titer with TKDTNNNLC in loop HI1 was the highest, with approximately 30% of wt P3 titer. This construct was used in trials to introduce the epitope coding sequence into the viral genome by homologous recombination as described elsewhere . However, these attempts failed. The remaining hybrid proteins gave titers two to three orders of magnitude lower than the wt control ( Table 1) . Because of the low biological functionality of the hybrid proteins, the corresponding genes were not selected for introduction into the viral genome.
Recombinant hybrid proteins were expressed and purified further for immunological analyses. Escherichia coli cells containing plasmids encoding wt or hybrid P3 protein were grown as described under Materials and methods. At 37°C, all P3 protein was found almost entirely in the particulate fraction with only trace amounts in the supernatant. P3 yield was approximately 40 -50 mg l Ϫ1 . At 18°C, ϳ90% of wt P3 was soluble, whereas hybrid protein constructs could not be rescued from the particulate fraction (data not shown). Immunoblotting with meningococcal P1.16 epitope-specific mouse monoclonal antibody MN12H2 confirmed presence of epitope in the hybrid (Fig. 2) . This monoclonal antibody reacted also with a 40-kDa host protein present in the whole cell sample (Fig. 2) , but not in the purified virus preparate.
The vertex protein P5 has a domain structure where the carboxyl-terminal domain and the linker region are accessible from outside
Because the major coat protein derivatives aggregated when produced from expression vectors, the ability of trimeric vertex protein P5 to carry the meningococcal P1.16 epitope was probed. By using amber mutant viruses sus691, sus692, and sus693 to express truncated versions of the vertex protein (depicted in Fig. 3) , it was shown that the amino terminal region is associated with the capsid (Bamford and . Amber mutants were analyzed further by immuno-centrifugation to determine which portion of the carboxyl-terminal domain protrudes from the virion surface. The assay was first optimized using wt PRD1 particles and polyclonal serum against the vertex protein P5. In optimized antibody/virus ratios (1/50 antiserum dilution) an additional, faster moving zone was detected in the rate zonal sucrose gradient containing virus particles (Fig. 4) . Caldentey et al., 2000) . Locations of amber codons (in sus691, sus692 and sus693) as well as locations of inserted epitopes (1-8; for the exact location of the insertion see Table 2 ) are marked with arrows. The amino acid sequence of the linker region is indicated. Underlined is the collagen-like motif as well as the polyglycine stretch.
The new zone corresponded to aggregates of two PRD1 particles as approximated from the sedimentation velocity and negative stain EM analysis (Fig. 4) . In a control experiment with antiserum against the coat protein P3, all virus material was always detected either in a zone with the velocity of single virus particles or in the pellet fraction, depending on the antibody concentration. The double virus zone was also obtained by using antisera against two other vertex proteins, P2 and P31 (data not shown). The assay with P5-specific antiserum was repeated by using purified sus691 (Fig. 4) , sus692 and sus693 particles carrying P5 truncations and, as a control, sus690 particles entirely missing P5. Sus690 particles did not form the double virus zone under the conditions used whereas all particles carrying truncated P5 did. The results show that even the shortest version of P5 with 149 amino acids is accessible to antibodies on a virion surface.
P5 proteins carrying the meningococcal epitope in their carboxyl-terminal domain are biologically active
Secondary structure prediction for protein P5 (PHDsec; Sander, 1993, 1994 ) resulted in a model with a repeating pattern of loops and ␤-strands, similar to the ␤-spiral fold in adenovirus fiber shaft (van Raaij et al., 1999) . It was shown earlier that the P5 amino terminus is homologous to P31 (Caldentey et al., 2000) . Optimal alignment of P5 and P31 amino termini was calculated to predict structure more reliably. For the carboxyl terminus no homologous proteins exist, so secondary structure was predicted based on P5 sequence alone. Insertion sites were chosen to match predicted loop areas. Positions of the constructed meningococcal insertions are indicated in Table 2 and Fig. 3 . Two insertions were made within the aminoterminal domain, two within the flexible linker region, and four within the carboxyl-terminal domain. The biological activity of the hybrid proteins was tested by complementation analysis. The titer of P5 Ϫ mutant sus690 was determined on a bacterial strain carrying different recombinant plasmids with hybrid gene V ( Table 2) . Hybrid vertex proteins with N-terminal insertions were not able to rescue the defect in sus690, giving titers only slightly higher than background. Linker region insertions, 3 and 4 ( Fig. 3 ; Table  2 ), resulted in titers of one order of magnitude higher than background. In contrast, all hybrid proteins with C-terminal insertions rescued the defect in P5 ( Table 2) . The best insertion, 5 ( Fig. 3 ; Table 2 ), produced a titer almost as high as the positive control (wt gene V). In this construct, the epitope was inserted between adjacent amino acids (T200 and D201) whereas in the other three functional constructs, wt amino acids were replaced (Table 2) . 
Analysis of the recombinant spike protein
Hybrid gene V from construct 5, which gave the best complementation titer, was recloned into an expression vector, overexpressed, and then purified as described under Materials and methods. In a pattern similar to wt, the overexpressed recombinant protein eluted in several peaks from an anion exchange and gel filtration column, with peaks representing multimeric forms of the protein as shown earlier (Caldentey et al., 2000) . This indicates that the overexpressed recombinant spike protein is capable of forming dimers, trimers, and nonamers by interacting via the amino-terminal domain as shown for the wt protein (Sokolova et al., 2001) . The purified recombinant protein was analyzed by Western blotting using P5-specific antiserum and Mab MN12H2, which recognizes the meningococcal P1.16 epitope. Both gave a strong signal, confirming that the purified spike protein carried the epitope (Fig. 5) .
Recombinant PRD1 gene V coding the meningococcal epitope can be inserted into the viral genome resulting in viable virus
The hybrid gene V carrying the epitope between amino acids T200 and D201 (construct 5; Fig. 3 ) was introduced into the genome of PRD1. The presence of the epitope in purified virions was confirmed by Western blotting using Mab MN12H2 against the meningococcal P1.16 epitope (Fig. 5) . The presence of all spike complex proteins (P2, P5, and P31) in normal amounts was also confirmed using specific antisera (Fig. 5) . This demonstrates that the particle is replication competent with no variations in protein stoichiometry. The stability of the recombinant virus was followed for 3 months by titering the phage every second week. No difference in stability compared to wt particles was detected (data not shown). However, compared to the wt virus, a difference in the binding of the recombinant virus to the host cell was observed (Fig. 6) . The binding rate constant of the recombinant virus was 0.29 Ϯ 0.07 min Ϫ1 , which is significantly smaller than that of wt (0.48 Ϯ 0.02 min
Ϫ1
).
Probing the role of the linker region in the spike protein P5
Protein P5 domain structure is depicted in Fig. 3 . To analyze the function of the collagen-like motif and the eight glycine residue stretch, these sequences were deleted by site-directed mutagenesis from plasmids containing wt gene V. Resulting plasmids with deletions ⌬collagen and ⌬G 8 were able to complement the defect in sus690, a P5-deficient mutant, revealing that these gene V deletion constructs were functional (Table 2 ). The constructs were further introduced from the plasmid into the phage genome by homologous recombination as described under Materials and Walin et al., 1994) . This shows that the deletion proteins, in addition to the epitope insertion construct (see above), can be incorporated into viable particles when produced under the physiological conditions of a standard PRD1 infection. The kinetics of the binding of the two spike protein deletion mutant particles to the host receptor was determined (Fig. 6) . Curves obtained from an exponential model fitted experimental data very well (regression coefficients Ͼ 0.98). In equilibrium, 96 Ϯ 0.72% of the wt virus is bound. Deletion of the collagen-like motif had a severe effect on binding efficiency (only 44 Ϯ 2.1% of virus particles bound at equilibrium), although the binding rate constant (0.67 Ϯ 0.18 min Ϫ1 ) was comparable to that of wt (0.48 Ϯ 0.019 min Ϫ1 ). With deletion of eight glycine residues, the rate constant (0.20 Ϯ 0.038 min Ϫ1 ) was significantly lower than that of wt but binding efficiency was nearly sustained (83 Ϯ 4.6%).
Immunological properties of the hybrid proteins and viruses
Enzyme-linked immunosorbent assay (ELISA) experiments, with monoclonal antibodies (MN12H2, MN5C11G, 62D12-8) and polyclonal antibody (HH898) confirmed that the P1.16 epitope is present and exposed on recombinant proteins purified in a denatured form (data not shown). The immunogenicity of the constructions was tested in mice and the postimmunization sera were analyzed by ELISA. Despite good immunogenicity of wt coat protein, only marginal antibody responses to both native porA (capsular polysaccharide-depleted whole meningococcal cells) and denatured recombinant porA protein (isolated from inclusion bodies) were observed (data not shown).
In contrast to the immunoblotting studies with the specific Mab MN12H2 (Fig. 5) , the PRD1-[GTKDTNNNL]-1 recombinant phage failed to show positive reaction in ELISA with the panel of P1.16-specific murine monoclonal and polyclonal antibodies tested (data not shown). This suggests that the inserted TKDTNNNL epitope is not properly exposed or the antibodies do not recognize its conformation. This is further supported by the fact that neither the purified hybrid protein nor the hybrid phage were able to raise proper immune response in either mice or rabbits.
Discussion
Several alterations were introduced to the coat (P3) and spike (P5) proteins of PRD1. Although only a short insertion was used and its position was modeled to the most distal exposed loops of the coat protein, the functionality of P3 was severely impaired in four cases out of five as measured by their ability to complement P3-deficient viral particles. Alterations in the function of the epitope-carrying P3 proteins are most likely explained by an increased propensity to misfold, since the overexpressed recombinant proteins were not soluble at 18°C, while the wt protein was. On the other hand, it was possible to introduce both insertions and deletions into selected sites in the spike protein without drastically diminishing its function, except in cases where insertions were located in regions involved in anchoring the spike protein to the viral vertex. It is concluded that characteristics of altered P3 and P5 molecules are in line with the "self" hypothesis (Bamford, 2003; . According to this hypothesis, related viruses contain conserved elements (like the coat protein fold and its potential to form closed shells) that evolve slowly and may date back to viruses that existed before current domains of life were separated. It is proposed that these conserved elements form an innate viral "self" and can be used to classify viruses within lineages. Other elements may have evolved much more rapidly, allowing parasitic viruses to respond quickly to host cell changes. In contrast to surface loops of adenovirus hexon, all surface loops in PRD1 major coat protein are very short. In addition, they do not seem to tolerate even short insertions. This suggests that the PRD1 coat protein is in a deep evolutional minimum. In PRD1-like viruses isolated from around the world, few changes are found in the coat protein primary sequence (Benson et al., 2002) . In contrast, the extensive variable surface loops of adenovirus hexon change whenever the immune recognition system of the host is altered, and thus are not counted among adenoviral-conserved elements. Because the PRD1 capsid remains on the cell surface upon infection, it is proposed that PRD1 surface loops have been optimized to build a stable structure, and thus are conserved. On the other hand, the spike protein P5 is part of the receptor recognition complex; it must change rapidly to guarantee continuous and efficient binding to host cells.
The flexible spike structures composed of proteins P5 and P2 Caldentey et al., 2000; Sokolova et al., 2001) are not visible in icosahedrally averaged image reconstructions of PRD1 ( Fig. 1; San Martín et al., 2001 ) and are thus difficult to study. P5 alterations illustrate several key points (Figs. 3 and 6) . Removal of the eight glycine residues decreased adsorption rate but had little effect on adsorption efficiency, since after reaching a plateau, the fraction of bound virus particles was the same as for wt. This suggests reduced spike flexibility and, consequently, reduction in receptor searching space. Removal of the collagen motif had little effect on adsorption rate but adsorption efficiency was reduced to less than one-half. No reduction of receptor-binding protein P2 was observed, reflecting the possible role of the collagen motif in irreversible receptor binding and/or entry. Interestingly, in adenovirus with long fibers, such as types 2 and 5, both flexibility and shaft domain length seem to affect receptor usage (Chiu et al., 2001) . Recently, it was proposed that the distal region flexibility of reovirus attachment protein 1, a functionally related protein, has an important role in receptor binding (Chappell et al., 2002) . Organization of the P2-P5 complex is not known but recent advances in solving its structure (Xu et al., 2000 (Xu et al., , 2003 as well as the structure of the distal C-terminus of P5 (R. Tuma, personal communication) will lead to further understanding of structural details and help to interpret these results.
The nine amino acid structural probe of the group B meningococcal outer membrane protein PorA P1.16 epitope was selected because of its size and medical relevance as a vaccine candidate. A viral epitope carrier such as PRD1 with 720 coat and approximately 40 spike proteins could potentially elicit immunological responses against this severe bacterial pathogen with no effective subunit vaccine yet developed. The epitope was successfully inserted into four surface loops of P3 as indicated by Western blot and ELISA analyses. These chimeric proteins lost biological activity, however, and it was not feasible to construct a virus particle expressing the meningococcal epitope as part of the coat protein. Denatured chimeric P3 proteins can, however, be produced for immunological studies. Insertion of the meningococcal epitope into spike protein P5 yielded a functional protein and the corresponding construction could be incorporated into the viral genome, allowing expression of the epitope on the virus particle. This is proof of principle that a foreign epitope can be inserted into P5 and expressed on purified virion surfaces.
Immunization of mice or rabbits with chimeric denatured P3 protein or purified viral particles carrying chimeric P5 proteins elicited strong immune responses against carrier proteins but only weak responses against the meningococcal epitope inserted within the HI1 loop in protein P3. Other chimeric constructs did not show relevant responses. The ELISA signal of virus-associated epitopes was low, suggesting the epitope was not properly exposed. When the high-resolution structure of the C-terminal distal region of P5 is available, a better understanding of the epitope location will be obtained and a more rational design of P5 insertion sites allowed.
In this study, the feasibility of using PRD1 as a peptide display system was demonstrated. Further insights into the structure of the receptor-binding complex will permit a more detailed search for viable surface regions. The high yield and considerable purity of PRD1 particles (Walin et al., 1994) make this carrier complex an alternative for expressing multiple copies of epitopes on particle surfaces.
Materials and methods
Bacteria, phages, and plasmids
Bacterial strains and phages used in the study are listed in Table 3 . The cells were grown in Luria-Bertani (LB) medium (Sambrook and Russell, 2001) . When appropriate, tetracycline (10 g ml Ϫ1 ), cloramphenicol (25 g ml Ϫ1 ), or kanamycin (25 g ml Ϫ1 ) was added. Wt PRD1 and the recombinant phages PRD1-[GTKDTNNNL]-1, PRD1-[P5⌬G 8 ], and PRD1-[P5⌬collagen] were propagated on Salmonella enterica DS88 and the amber mutants sus14, sus690, sus692, and sus693 on their suppressor strains (Table 3). Strain SL5676 was used in the phage adsorption experiments as a receptorless control. E. coli DH5␣, HB101, and HMS174 were used as cloning hosts and HMS174(DE3) as an expression host. Marker exchange by homologous recombination between the PRD1 genome and the recombinant plasmid was performed in E. coli JM107(pJB15) and complementation experiments were carried out using strain HMS174(pLM2). Virus was purified as described earlier (Bamford and Bamford, 1991) except that the virus zone from the rate zonal sucrose gradient was further purified by ion exchange chromatography. For this either a Sartobind ion exchange filter D100X (Sartorius) or a MemSep DEAE cellulose filter (Millipore) was used (Walin et al., 1994) . Plasmids used in the study are listed in Table 4 .
Site-directed mutagenesis
Single-step recombination PCR (Jones and Howard, 1991) was used to obtain site-directed changes in low-copynumber plasmid pSU18-based vectors carrying gene III (pSH2) and V (pJB500 and pSH38) encoding proteins P3 and P5, respectively. Two primers having complementary 5Ј regions were used to produce a linear product with homologous ends containing designed changes. Amplifications were performed in 50-l volume of standard buffer with 2.5 U cloned Pfu polymerase (Stratagene), 25 pmol of primers, and 250 M each deoxynucleoside triphosphate (dNTP). Thermal cycling (30 cycles) was performed with the following parameters: 95°C for 30 s (initial denaturation for 2 min), 60 -70°C for 2 min, and 72°C for 7 min. The methylated circular parental DNA was digested at 37°C for at least 2 h with 10 U of DpnI prior to transformation into DH5␣ cells.
Silent point mutations were designed using EMBOSS software package (Rice et al., 2000) to create new restriction enzyme sites. A new site was introduced by Quick Change into plasmid pSH2 regions coding for the surface loops of the coat protein P3 (BC1, DE1, FG1, HI1, and HI1-␣), resulting in insertion vectors (pJTH7, 1, 17, 13, and 15, respectively; Table 4 ). The DNA sequence encoding the meningococcal PorA P1.16 surface epitope (TKDT-NNNLC) was inserted into all five vectors by recombination PCR resulting in plasmids pJTH19, 21, 23, 25, and 27 (Table 4) . A longer sequence with alanine residues flanking the meningococcal epitope (AAATKDTNNNLCAAA) was introduced in two loops, DE1 and HI1, resulting in plasmids pJTH39 and 41, respectively (Table 4) . Clones were screened by the disappearance of the restriction enzyme site unique to the vector. An overall frequency of approximately 85% of correct clones was observed. The same method was used for insertion of TKDTNNNLC epitope encoding sequence into eight different sites in gene V (pJTH70, 72, 74, 76, 78, 80, 82, and 84) and for deletion of the eight glycine residues (pSH12) and the collagen-like motif (pJTH109). Point mutations resulting in new restriction sites for screening clones were introduced simultaneously. Plasmid pJB500 or pSH38 was used as a template. Mutated plasmids were screened by the appearance of new restriction enzyme sites. Modifications were further verified by DNA sequencing.
Expression and analysis of the recombinant hybrid P3 proteins
To overexpress hybrid coat proteins, inserts from lowcopy-vector clones (pJTH19, 21, 23, 25, and 27) were recloned into high-copy-vector pJJ2, resulting in plasmids pSH21, 16, 17, 18, 19, and 20, respectively (Table 4) . Hybrid proteins and corresponding wt protein (pSH21) were expressed in E. coli K12 HMS174(DE3). Overnight cultures at 37 or 28°C were diluted 1/20 into L broth and growth was continued at 37 or 18°C, respectively. Cells were grown to approximately 3 ϫ 10 8 cells ml Ϫ1 and recombinant protein production was induced with 1 mM isopropyl-␤-D-thiogalactopyranoside (IPTG). Growth was continued for 3 h at 37°C or overnight at 18°C, after which cells were collected by centrifugation (Sorvall SS34 or GS3, 5°C, 10 min, 5000 rpm) and resuspended into 1/10 of original volume of 20 mM Tris-HCl, pH 7.4, buffer. Cells were broken by sonication for 2 min followed by a centrifugation step (Heraeus Biofuge Pico, RT [room temperature], 3 min, 10,000 rpm). Supernatant and pellet fractions were applied to SDS-PAGE analysis. Specificity of the protein bands was confirmed by Western blotting. P3 was detected either with monoclonal antibodies 3N180, 3N81, and 3T74 or with a polyclonal antibody against P3 and the meningococcal peptide with the monoclonal antibody MN12H2 (van den Elsen et al., 1997) specific for the PorA P1.16 serosubtype epitope. For large-scale purification of inclusion bodies, cells were disrupted by two passages through a French pressure cell (15,000 psi). Triton X-100 was added to a final concentration of 1%, and after 1 h incubation at RT, inclusion bodies were separated by centrifugation. Inclusion bodies were further purified by washing twice with detergent solution (phosphate-buffered saline [PBS] containing 3% Triton X-100, 2% Tween 20, 0.2% SDS) for 1 h at RT. This resulted in 60 -70% homogeneity, as estimated from Coomassie blue-stained SDS-PAGE. Final purification was per- Bamford and Bamford, 1990 PSA(pLM2) supE, suppressor host for sus14, sus690, and sus692 Mindich et al., 1982 DB7154(pLM2) supD, suppressor host for sus691 and sus693 Winston et al., 1979 Phages PRD1 wt Olsen et al., 1974 Amber mutation in gene III Mindich et al., 1982 sus690 Amber formed using preparative SDS-PAGE and passively eluting protein from gel slices into PBS containing 0.1% SDS. This resulted in nearly 100% homogeneity.
Expression and purification of the hybrid P5 protein
The hybrid gene V with the meningococcal epitope insertion giving the best complementation titer was recloned from pJTH78 into pET24 vector as an EcoRI-HindIII fragment resulting in plasmid pSN17. HMS174(DE3)(pSN17) cells were grown at 37°C to a density of about 2 ϫ 10 8 colony forming units (cfu) ml
Ϫ1
. After addition of IPTG to a final concentration of 1 mM, incubation was continued for 3 h. Cells were collected by centrifugation (Sorvall GS3 rotor, 5000 rpm, 10 min, 5°C), resuspended in 20 mM Tris-HCl, pH 7.2, 5% (v/v) glycerol (1/100th of the original culture volume), and frozen at Ϫ70°C. After thawing, cells were disrupted by a French press as described above and debris was removed by centrifugation (Sorvall SS34 rotor, 8000 rpm, 20 min, 5°C). The supernatant was further cleared (Beckman Ti50 rotor, 30,000 rpm, 2 h, 5°C) and proteins were precipitated by adding ammonium sulfate to 27% saturation. Precipitated material was collected (Sorvall SS34 rotor, 10,000 rpm, 30 min, 5°C) and resuspended in 20 mM Tris-HCl pH 7.2, 50 mM NaCl, and dialyzed overnight at 5°C against the same buffer. After clearing (Sorvall SS34 rotor, 10,000 rpm, 10 min, 5°C) the solution was applied to HI TRAP Q column (Pharmacia) and proteins were eluted with a linear 50 mM-1 M NaCl gradient in the same buffer. Fractions containing the hybrid P5 protein were collected and loaded on a Hi-Load Superdex 200 16/60 gel-filtration column (Pharmacia) equilibrated with 20 mM Tris-HCl, pH 7.2, 150 mM NaCl. Peak fractions containing hybrid P5 spike protein were collected. Table 4 Plasmids used in the study
Construction of the recombinant phages
In vivo homologous recombination was used to introduce hybrid or deleted gene V from plasmids into the virus genome as earlier described . The meningococcal insertion from pJTH78 and the collagen motif deletion from pJTH109 were recombined into the genome of PRD1 sus693. Recombination of the 8 glycine residue deletion from pSN12 into the virus was performed using the PRD1-[LacZ-␣]-15 phage, which was first constructed using the method described earlier . Phages and plasmids were allowed to recombine in vivo and resulting viruses were plated on S. enterica DS88 cells. The DNA from the plaques was analyzed by PCR. Plaques were first resuspended in 500 l of 20 mM Tris-HCl, pH 7.2, after which the material was divided into two aliquots. One aliquot was saved for phage recovery and the other was boiled for 5 min in the presence of 1% SDS to disrupt phage particles. A 1/10 dilution of this solution was used as a template in a PCR. Successful insertion of the epitope was confirmed by using primers designed to hybridize to the inserted DNA sequence and gene V, resulting in a specific 740-bp-long product. For the two deletion mutants, primers were designed to hybridize to gene V and the resulting PCR product was screened by the appearance of a new restriction site, which was originally designed into the primer used in the mutagenesis (NheI in the 8 glycine deletion and MluNI in the collagen motif deletion). Recombinant phages were purified as earlier described (Bamford and Bamford, 1991; Walin et al., 1994) .
Phage adsorption assay
Cells were grown in LB medium to optimal adsorption phase (2 ϫ 10 9 cfu ml Ϫ1 ; Kotilainen et al., 1993) . Host cells (100 l) were mixed with approximately 300 phage particles and the mixture was incubated at 22°C for 1, 5, 10, and 15 min. Cells were collected by centrifugation (5000 rpm, 3 min, 22°C) and the number of free (nonadsorbed) phage particles was determined by plating supernatant on S. enterica DS88 cells.
Analytical and immunological methods
SDS-PAGE was performed as earlier described (Olkkonen and Bamford, 1989) . Proteins were either stained with Coomassie brilliant blue or transferred for Western blotting onto a polyvinylidene difluoride membrane (Millipore) and detected with antibodies. Polyclonal antisera recognizing phage PRD1, proteins P3 (Hänninen et al., 1997) , P5 (Hänninen et al., 1997) , P2 (Grahn et al., 1999) , or P31 (Rydman et al., 1999) , and the monoclonal antibody MN12H2 (van den Elsen et al., 1997) specific for the meningococcal P1.16 PorA sequence TKDTNNNL were used. The chemiluminescent detection of peroxidase-conjugated secondary antibodies was performed using either the ECLplus (Amersham) or the Super Signal West Pico system (Pierce). Protein concentration of recombinant protein and virus preparates was determined using bovine serum albumin as a standard (Bradford, 1976) .
Surface location of truncated P5 proteins was analyzed by an immunocentrifugation assay. One hundred microliters of the MemSep DEAE cellulose-purified phage particles (corresponding to 9.5 ϫ 10 11 particles and 100 g of protein) was incubated with 100 l of antiserum dilution (1/5, 1/50) at 22°C for 60 min. The mixture was analyzed in a linear 5-20% (w/v) rate zonal sucrose gradient in 10 mM KPHO 4 , pH 7.2 (Sorvall TH641, 24,000 rpm, 55 min, 15°C). The light scattering zones were illuminated in the BioComp fraction collector sample chamber and photographed. Negative staining was carried out using 1% ammonium molybdate (pH 6.5) and the micrographs were recorded using a JEOL 1200 EX electron microscope operating at 60 kV.
Antigenicity of recombinant proteins and virus was analyzed by ELISA using meningococcal P1.16 epitopespecific monoclonal antibodies (MN12H2, MN5C11G, 62D12-8; National Institute of Public Health and the Environment [RIVM], The Netherlands) and polyclonal mouse serum (HH898, KTL, Finland). Peroxidase-conjugated rabbit immunoglobulins (Ig) to mouse Igs (P0260, Dako Immunoglobulins), diluted 1:4000 in PBS-10% Fetal calf serum, were used as secondary antibodies. 3,3Ј,5,5Ј-tetramethylbenzidine (Sigma; 0.4 mM in 0.11 M sodium acetate buffer containing 0.006% H 2 O 2 ) was used as a substrate.
To test immunogenicity of the meningococcal insertion sequence displayed on purified hybrid P3 protein, or on P5 protein on the virus surface, the antigen was introduced into mice. Groups of five 7-week-old outbred female Neu:NIH/s mice were injected three times subcutaneously with 20 g of protein or 20 or 50 g of the virus in a final volume of 0.2 ml on Days 0, 28, and 56. Control animals received only PBS. Freund's complete adjuvant was used in the first and AlPO 4 in the second and third immunization. The animals were bled on Day 63 and the sera analyzed by ELISA for antibody responses to the wild-type PRD1 and to the meningococcal P1.16 epitope both in the denatured (recombinant protein isolated from inclusion bodies) and in the native form (capsular polysaccharide-depleted whole meningococcal cells) (Nurminen et al., 1992) .
The immunogenicity of hybrid P5 protein and the recombinant PRD1-[GTKDTNNNL]-1 was further tested in rabbits. In the primary immunization the antigen was injected subcutaneously with Freund's complete adjuvant followed by two boosters in Freund's incomplete adjuvant. A dose of 200 and 500 g of the antigen was used for hybrid protein and phage particles, respectively. Boosters were given at 3-week intervals and serum was collected 2 weeks after the final booster.
